CVS Health Corporation (CVS)

[DiscoverGold]

CVS Health Corp earnings beat by $0.07, revenue topped estimates
By: Investing.com | February 8, 2023

CVS Health Corp (NYSE: CVS) reported fourth quarter EPS of $1.99, $0.07 better than the analyst estimate of $1.92. Revenue for the quarter came in at $83.85B versus the consensus estimate of $76.33B.

Guidance

CVS Health Corp sees FY 2023 EPS of $8.70-$8.90 versus the analyst consensus of $8.86.

CVS Health Corp's stock price closed at $85.98. It is down -11.86% in the last 3 months and down -17.95% in the last 12 months.

CVS Health Corp saw 5 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See CVS Health Corp's stock price’s past reactions to earnings here.

According to InvestingPro, CVS Health Corp's Financial Health score is "great performance".

Check out CVS Health Corp's recent earnings performance, and CVS Health Corp's financials here.

Read Full Story »»»

DiscoverGold